CSIMarket
 


Zynex inc   (ZYXI)
Other Ticker:  
 

Zynex Inc 's Working Capital Ratio

ZYXI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the forth quarter 2023, Working Capital Ratio deteriorated to 6.01 above company average Working Capital Ratio.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Working Capital Ratio than Zynex Inc in forth quarter 2023. While Working Capital Ratio total ranking in the forth quarter 2023 has deteriorated compared to the prior quarter from 36 to 336.

Explain Working Capital Ratio
How much in Current Assets ZYXI´s has?
What is the value of ZYXI´s Current Liabilities?


ZYXI Working Capital Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Change -30.73 % -16.23 % -25.12 % -5.85 % -7.8 %
Y / Y Current Assets Change 26.3 % 52.75 % 52.29 % -20.7 % -15.88 %
Working Capital Ratio MRQ 6.01 6.21 7.63 3.09 3.3
ZYXI's Total Ranking # 336 # 36 # 644 # 113 # 0
Seq. Current Liabilities Change -11.8 % 17.5 % -33.07 % -0.13 % 6.66 %
Seq. Current Assets Change -14.64 % -4.31 % 65.06 % -6.32 % 3.23 %



Working Capital Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 108
Overall Market # 336


Working Capital Ratio Statistics
High Average Low
10.34 3.41 0.37
(Sep 30 2020)   (Dec 31 2015)




Financial Statements
Zynex Inc 's Current Liabilities $ 15 Millions Visit ZYXI's Balance sheet
Zynex Inc 's Current Assets $ 88 Millions Visit ZYXI's Balance sheet
Source of ZYXI's Sales Visit ZYXI's Sales by Geography


Cumulative Zynex Inc 's Working Capital Ratio

ZYXI's Working Capital Ratio for the trailling 12 Months

ZYXI Working Capital Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth -30.73 % -16.23 % -25.12 % -5.85 % -7.8 %
Y / Y Current Assets TTM Growth 26.3 % 52.75 % 52.29 % -20.7 % -15.88 %
Working Capital Ratio TTM 5.48 4.74 4.07 3.38 3.53
Total Ranking TTM # 1971 # 3811 # 415 # 4665 # 0
Seq. Current Liabilities TTM Growth -11.8 % 17.5 % -33.07 % -0.13 % 6.66 %
Seq. Current Assets TTM Growth -14.64 % -4.31 % 65.06 % -6.32 % 3.23 %


On the trailing twelve months basis ZYXI Current Assets grew by 26.3 % in IV Quarter 2023 year on year, while Current Liabilities fell to $15 millions, this led to increase in in Zynex Inc 's Working Capital Ratio to 5.48, above ZYXI average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 106 other companies have achieved higher Working Capital Ratio than Zynex Inc . While Working Capital Ratio overall ranking has improved so far to 1971, from total ranking during the twelve months ending third quarter 2023 at 3811.

Explain Working Capital Ratio
How much in Current Assets ZYXI´s has?
What is the value of ZYXI´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 107
Healthcare Sector # 373
Within the Market # 1971


trailing twelve months Working Capital Ratio Statistics
High Average Low
6.83 3.2 0.42
(Jun 30 2021)   (Sep 30 2016)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Inmode Ltd   15.89 $ 845.330  Millions$ 53.213  Millions
Cvrx inc  14.25 $ 112.090  Millions$ 7.864  Millions
Alpha Tau Medical Ltd   14.20 $ 85.756  Millions$ 6.040  Millions
Semler Scientific Inc   12.98 $ 65.944  Millions$ 5.080  Millions
Shockwave Medical Inc   11.76 $ 1,225.260  Millions$ 104.205  Millions
Novocure Limited  10.96 $ 1,034.409  Millions$ 94.391  Millions
Co diagnostics Inc   10.81 $ 62.141  Millions$ 5.748  Millions
Axonics Inc   10.73 $ 491.422  Millions$ 45.816  Millions
Medinotec Inc   10.69 $ 3.594  Millions$ 0.336  Millions
Orasure Technologies Inc  9.77 $ 386.459  Millions$ 39.536  Millions
Si bone inc   9.59 $ 211.394  Millions$ 22.040  Millions
Fonar Corporation  9.35 $ 132.542  Millions$ 14.179  Millions
Silk Road Medical Inc   7.95 $ 240.835  Millions$ 30.283  Millions
Procept Biorobotics Corporation  7.63 $ 350.567  Millions$ 45.927  Millions
Inspire Medical Systems inc   7.60 $ 593.739  Millions$ 78.105  Millions
Inspiremd Inc   7.34 $ 44.159  Millions$ 6.020  Millions
Orthopediatrics Corp  7.19 $ 226.496  Millions$ 31.517  Millions
Profound Medical Corp   6.58 $ 41.896  Millions$ 6.366  Millions
Lemaitre Vascular Inc   6.51 $ 194.598  Millions$ 29.879  Millions
Pulmonx Corporation  6.50 $ 150.422  Millions$ 23.157  Millions
The Beauty Health Company  6.07 $ 698.252  Millions$ 115.008  Millions
Penumbra Inc   6.06 $ 915.402  Millions$ 151.144  Millions
Zynex inc   6.01 $ 87.855  Millions$ 14.607  Millions
Electromed Inc   5.97 $ 39.265  Millions$ 6.573  Millions
Merit Medical Systems Inc  5.79 $ 1,108.470  Millions$ 191.477  Millions
Tandem Diabetes Care Inc   5.57 $ 747.989  Millions$ 134.204  Millions
Glaukos Corp  5.34 $ 395.461  Millions$ 74.014  Millions
Anika Therapeutics Inc   5.26 $ 163.309  Millions$ 31.059  Millions
Monogram Orthopaedics inc   5.19 $ 14.618  Millions$ 2.818  Millions
Nephros Inc   5.04 $ 8.405  Millions$ 1.667  Millions

Date modified: 2024-03-13T04:00:45+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com